The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
bioquanta | 49 |
bio-rad innovations | 24 |
ariana pharmaceuticals | 23 |
etablissement francais du sang | 22 |
carthera | 18 |
diagnostica stago | 18 |
nls pharma | 17 |
cytune pharma | 15 |
dbv technologies | 12 |
integragen | 10 |
cytune pharma | 5 |
rarecells | 4 |
etablissement francais du sang | 3 |
nls pharma | 2 |
genentech | 2 |
curis | 2 |
carthera | 2 |
integragen | 2 |
bioquanta | 2 |
intrasense | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
use of biotin for the treatment of multiple sclerosis | 40 | 2012 |
phacetoperane for the treatment of attention-deficit hyperactivity disorder | 26 | 2011 |
mazindol combination in the treatment of attention deficit/hyperactivity | 23 | 2006 |
method for producing platelets | 23 | 2008 |
use of low dose il-2 for treating autoimmune - related or inflammatory disorders | 23 | 2011 |
site-specific intestinal delivery of adsorbents, alone or in combination with degrading … 🛈 | 22 | 2006 |
pharmaceutical compositions highly dosed with biotin | 21 | 2010 |
il-15 and il-15raplha sushi domain based modulokines | 21 | 2013 |
medicament for treating parkinson's disease | 21 | 2007 |
cell culture medium for the growth and differentiation of cells of the hematopoietic lin… 🛈 | 20 | 2010 |